Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” (EClinicalMedicine (2021) 40, (S2589537021004053), (10.1016/j.eclinm.2021.101125))

Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, Anna Annunziata, Mariano Bernardo, Angela Lombardi, Valentina Trimarco, Gaetano Santulli, Bruno Trimarco

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” (EClinicalMedicine (2021) 40, (S2589537021004053), (10.1016/j.eclinm.2021.101125))'. Together they form a unique fingerprint.

Medicine & Life Sciences